Literature DB >> 28903863

Effectiveness trials in asthma: time to SaLSA?

Peter Gibson1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28903863     DOI: 10.1016/S0140-6736(17)32398-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Combination of TLR agonist and miR146a mimics attenuates ovalbumin-induced asthma.

Authors:  Xinhua Wang; Xiaoxian Lu; Chenhui Ma; Lihong Ma; Shuguang Han
Journal:  Mol Med       Date:  2020-06-29       Impact factor: 6.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.